Barriers to insulin initiation: The Translating Research Into Action for Diabetes (TRIAD) Insulin Starts Project
- Andrew J. Karter, PhD (andy.j.karter{at}kp.org)1,
- Usha Subramanian, MD, MS2,
- Chandan Saha, PhD3,
- Jesse C Crosson, PhD4,
- Melissa M Parker, MS1,
- Bix E. Swain, MS1,
- Howard H. Moffet, MPH1 and
- David G. Marrero, PhD2
- 1. Kaiser Permanente - Division of Research, Oakland, CA 94612
- 2. National Institute for Fitness and Sport, Indiana University, Indianapolis 46202
- 3. Indiana University, Indianapolis, Indiana 46202
- 4. UMDNJ-Robert Wood Johnson Medical School - Department of Family Medicine, Somerset, New Jersey 08873
Abstract
Objective- Reasons for failing to initiate prescribed insulin (primary non-adherence) are poorly understood. We investigated barriers to insulin initiation following a new prescription.
Research design and methods - We surveyed insulin-naïve patients with poorly controlled type 2 diabetes, already treated with ≥2 oral agents who were recently prescribed insulin. We compared responses for respondents prescribed, but never initiating, insulin (n=69) to those dispensed insulin (n=100).
Results - Subjects failing to initiate prescribed insulin commonly reported misconceptions regarding insulin risk (35% believed that insulin causes blindness, renal failure, amputations, heart attacks, strokes or early death); plans to instead work harder on behavioral goals; sense of personal failure; low self-efficacy, injection phobia; hypoglycemia concerns; negative impact on social life and job; inadequate health literacy; healthcare provider inadequately explaining risks/benefits; and limited insulin self-management training.
Conclusions - Primary adherence for insulin may be improved through better provider communication regarding risks, shared decision making, and insulin self-management training.
Footnotes
-
- Received June 20, 2009.
- Accepted January 6, 2009.
- Copyright © American Diabetes Association











